I. Scott

发表

Suspected very early inflammatory rheumatic diseases in primary care.

S. Hider, C. Mallen, L. Warburton, 2019, Best practice & research. Clinical rheumatology.

How can primary care physicians enhance the early diagnosis of rheumatic diseases?

C. Mallen, I. Scott, T. Helliwell, 2018, Expert review of clinical immunology.

Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies

G. Kingsley, S. Steer, F. Ibrahim, 2016, BMC Musculoskeletal Disorders.

Do Genetic Susceptibility Variants Associate with Disease Severity in Early Active Rheumatoid Arthritis?

Y. Okada, C. Lewis, S. Raychaudhuri, 2015, The Journal of Rheumatology.

Anti-Tumour Necrosis Factor-Alpha (TNF-α) Treatment

D. Scott, J. Galloway, I. Scott, 2015 .

Basic science232. Certolizumab pegol prevents pro-inflammatory alterations in endothelial cell function

H. L. Wright, R. Moots, T. Spector, 2012 .

Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data

Ehrenstein, I. Bruce, Jane Worthington, 2018, RMD Open.

Clinical and Laboratory Assessments

D. Scott, J. Galloway, I. Scott, 2015 .

An Overview of Inflammatory Arthritis

D. Scott, J. Galloway, I. Scott, 2015 .

Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?

S. Hider, D. Scott, I. Scott, 2018, Drug Safety.

OP-RAPC180011 1..6

S. Hider, C. Mallen, K. Raza, 2018 .

Clinical and Serological Predictors of Remission in Rheumatoid Arthritis Are Dependent on Treatment Regimen

A. Cope, D. Scott, I. Scott, 2014, The Journal of Rheumatology.

Antibiotic use and the risk of rheumatoid arthritis: a population-based case-control study

S. Hider, C. Mallen, L. Hall, 2019, BMC Medicine.

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

Francisco Bonachela Capdevila, I. Bruce, Jane Worthington, 2022, Scientific Data.

Current limitations in the management of cardiovascular risk in rheumatoid arthritis.

G. Kingsley, F. Ibrahim, D. Scott, 2012, Clinical and experimental rheumatology.

Defining the relationship between pain intensity and disease activity in patients with rheumatoid arthritis: a secondary analysis of six studies

F. Ibrahim, D. Scott, I. Scott, 2022, Arthritis Research & Therapy.

A case series and systematic literature review of anakinra and immunosuppression in idiopathic recurrent pericarditis.

P. Hawkins, H. Lachmann, I. Scott, 2011, Journal of cardiology cases.

Genetic and environmental risk factors for rheumatoid arthritis in a UK African ancestry population: the GENRA case (cid:2) control study

G. Breen, S. Newhouse, H. Patel, 2017 .

Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis?

G. Kingsley, D. Scott, I. Scott, 2013, Clinical and experimental rheumatology.

Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis

P. Gregersen, Y. Kamatani, Y. Okada, 2022, Nature Genetics.

Clinical decision-making in remote rheumatology consultations: a service evaluation of new patient and inflammatory rheumatic disease follow-up appointments

Z. Paskins, I. Scott, J. Weddell, 2021, Rheumatology advances in practice.

Biologics – An Overview

D. Scott, J. Galloway, I. Scott, 2015 .

Disease-Modifying Anti-Rheumatic Drugs

D. Scott, J. Galloway, I. Scott, 2015 .

The Impact of Targeted Rheumatoid Arthritis Pharmacologic Treatment on Mental Health

M. Hotopf, S. Steer, F. Matcham, 2018, Arthritis & rheumatology.

Prediction model for rheumatoid arthritis: modelling 46 genetic risk variants with smoking

C. Lewis, A. Barton, A. Hinks, 2013, The Lancet.

Trans-ancestry genome-wide association study identifies novel genetic mechanisms in rheumatoid arthritis

P. Gregersen, Y. Kamatani, Y. Okada, 2021, medRxiv.

Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients

Borbala Mifsud, Felix Agakov, Paul McKeigue, 2018, The Pharmacogenomics Journal.

Precipitating and perpetuating factors of rheumatoid arthritis immunopathology: linking the triad of genetic predisposition, environmental risk factors and autoimmunity to disease pathogenesis.

C. Lewis, S. Steer, A. Cope, 2011, Best practice & research. Clinical rheumatology.

Polycythaemia rubra vera and myelofibrosis with spinal cord compression

I. Scott, C. Poynton, 2008, Journal of Clinical Pathology.

The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis.

M. Hotopf, G. Kingsley, S. Steer, 2014, Seminars in arthritis and rheumatism.

Key findings from studies of methotrexate tapering and withdrawal in rheumatoid arthritis

S. Subesinghe, I. Scott, 2015, Expert review of clinical pharmacology.

Remission in Early Rheumatoid Arthritis

G. Kingsley, D. Scott, I. Scott, 2010, The Journal of Rheumatology.

Analgesic prescribing in patients with inflammatory arthritis in England: an observational study using electronic healthcare record data

C. Mallen, S. Muller, J. Bailey, 2021, Rheumatology.

ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial

C. Lewis, A. Cope, D. Scott, 2014, Arthritis Research & Therapy.

Payers' views on treating-to-target in rheumatoid arthritis: an English perspective.

A. Wailoo, D. Scott, I. Scott, 2012, Clinical and experimental rheumatology.

Risk prediction in rheumatoid arthritis

I. Scott, 2014 .

Predicting the Risk of Rheumatoid Arthritis and Its Age of Onset through Modelling Genetic Risk Variants with Smoking

C. Lewis, A. Barton, S. Eyre, 2013, PLoS genetics.

The protective effect of alcohol on developing rheumatoid arthritis: a systematic review and meta-analysis.

C. Lewis, D. Ståhl, S. Steer, 2013, Rheumatology.

Quality of life and the outcome of established rheumatoid arthritis.

G. Kingsley, D. Scott, I. Scott, 2011, Best practice & research. Clinical rheumatology.

The association between anxiety and disease activity and quality of life in rheumatoid arthritis: a systematic review and meta-analysis

S. Hider, C. Chew‐Graham, O. Babatunde, 2020, Clinical Rheumatology.

The association between gravidity, parity and the risk of developing rheumatoid arthritis: A systematic review and meta-analysis.

S. Hider, C. Mallen, S. Subesinghe, 2020, Seminars in arthritis and rheumatism.

B-Cell Inhibition and Other Biologics

D. Scott, J. Galloway, I. Scott, 2015 .

Rheumatoid arthritis severity: its underlying prognostic factors and how they can be combined to inform treatment decisions

C. Lewis, S. Steer, A. Cope, 2013 .

The Relationship Between Mental Health, Disease Severity, and Genetic Risk for Depression in Early Rheumatoid Arthritis

M. Hotopf, C. Lewis, S. Steer, 2017, Psychosomatic medicine.

Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases

P. Gregersen, J. Barrett, C. Lewis, 2019, PloS one.

Symptomatic drug treatment

D. Scott, J. Galloway, I. Scott, 2015 .

Impact of intensive treatment and remission on health-related quality of life in early and established rheumatoid arthritis

C. Lewis, V. Strand, F. Ibrahim, 2016, RMD Open.

The extra-articular impacts of rheumatoid arthritis: moving towards holistic care

S. Hider, C. Mallen, A. Machin, 2018, BMC Rheumatology.

Factors associated with disability in patients with rheumatoid arthritis with persistent moderate disease activity: a retrospective cohort study

B. Kirkham, J. Mount, I. Scott, 2020, BMC Rheumatology.

Symptoms associated with inflammatory arthritis are common in the primary care population: results from the joint symptoms survey.

S. Hider, D. van Schaardenburg, C. Mallen, 2019, Rheumatology.

Primary care challenges in diagnosing and referring patients with suspected rheumatoid arthritis: a national cross-sectional GP survey

S. Hider, C. Mallen, K. Raza, 2018, Rheumatology advances in practice.

Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis

G. Kingsley, A. Cope, A. Wailoo, 2019, BMC Rheumatology.

Spleen Tyrosine Kinase Inhibitors for Rheumatoid Arthritis: Where Are We Now?

D. Scott, David L. Scott, I. Scott, 2014, Drugs.

T rans-ancestry genome-wide association study identifies novel genetic mechanisms in rheumatoid 2 arthritis 3

P. Gregersen, Y. Kamatani, Y. Okada, 2021 .

S-8 Joint counts in inflammatory arthritis /

D. Scott, I. Scott, 2014 .

Stratified Medicine in Inflammatory Arthritis

D. Scott, J. Galloway, I. Scott, 2015 .

Emerging Therapies in Rheumatoid Arthritis

D. Scott, J. Galloway, I. Scott, 2015 .

Comparative quality of life in patients with depression and rheumatoid arthritis

G. Thornicroft, F. Ibrahim, T. Kendrick, 2011, International review of psychiatry.

Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: An observational study using primary care electronic health record data

S. Hider, K. Jordan, C. Mallen, 2022, The Lancet Regional Health - Europe.

Genetic and environmental risk factors for rheumatoid arthritis in a UK African ancestry population: the GENRA case–control study

G. Breen, C. Lewis, R. Dobson, 2017, Rheumatology.

Cost-effectiveness of treatment strategies using combination disease-modifying anti-rheumatic drugs and glucocorticoids in early rheumatoid arthritis.

A. Wailoo, F. Ibrahim, D. Scott, 2014, Rheumatology.

Joint counts in inflammatory arthritis.

D. Scott, I. Scott, David Scott, 2014, Clinical and experimental rheumatology.

The frequency of remission and low disease activity in patients with rheumatoid arthritis, and their ability to identify people with low disability and normal quality of life.

A. Cope, B. Kirkham, F. Ibrahim, 2019, Seminars in arthritis and rheumatism.

Epidemiology and Pathology

D. Scott, J. Galloway, I. Scott, 2015 .

M. Hotopf, S. Steer, F. Matcham, 2019, Arthritis & rheumatology.

Letter to the editor: The impact of targeted rheumatoid arthritis pharmacologic treatment on mental health: A systematic review and meta-analysis: Reply

M. Hotopf, S. Steer, F. Matcham, 2019 .

The Impact of Targeted Rheumatoid Arthritis Pharmacologic Treatment on Mental Health

M. Hotopf, S. Steer, F. Matcham, 2018, Arthritis & rheumatology.

The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: A systematic review and meta-analysis Seminars in Arthritis and Rheumatism

M. Hotopf, G. Kingsley, S. Steer, 2014 .

A randomised trial evaluating anakinra in early active rheumatoid arthritis.

F. Ibrahim, D. Scott, A. Hassell, 2016, Clinical and experimental rheumatology.

A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2

M. Shankar-Hari, H. Pandya, D. Saralaya, 2023, ERJ open research.

Comparative quality of life in patients with depression and rheumatoid arthritis

G. Thornicroft, F. Ibrahim, T. Kendrick, 2011, International Review of Psychiatry.

O38 The relationship between obesity and outcomes in patients with polymyalgia rheumatica

S. Hider, R. Bajpai, C. Mallen, 2020 .